Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NS106014, R03NS112760)
Lundbeck Foundation (LF-R349-2020-658)
Novo Nordisk Foundation (NNF21OC0067769)
NIH BRAIN Initiative
NIH Common Fund
American Academy of Neurology (Palatucci Advocacy Award)
Article History
Received: 3 October 2024
Accepted: 30 October 2024
First Online: 20 January 2025
Declarations
:
: Jan Claassen is a minority shareholder at iCE Neurosystems. Funding support from the National Institute of Neurological Disorders and Stroke (NINDS; R01NS106014, R03NS112760).